- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00806403
Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction (SWEDES)
Very Early Initiation of Treatment With Thrombolysis and Low Molecular Weight Heparin, Versus Abciximab and Low Molecular Weight Heparin Followed by Percutaneous Coronary Intervention, for Acute ST-Elevation Myocardial Infarction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients in the fibrinolytic group received an intravenous injection of 30 mg enoxaparin followed by subcutaneous injections of 1 mg/kg body weight every 12 hours during hospital stay.
Patients in the invasive group were given an intravenous injection of enoxaparin of (0.75 mg/kg body weight) and abciximab as a intravenous bolus (0.25 mg/kg body weight) followed by a 12 hour infusion (10 microg/minute).
Secondary outcome measures were death, myocardial infarction and stroke alone or as a composite at 30 days.
Data on use of health care resources, loss of production and health-related quality of life were collected during one year. Cost-effectiveness was determined by comparing costs and quality-adjusted survival.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Gothenburg, Sweden
- Sahlgrenska University Hospital
-
Orebro, Sweden
- Orebro University Hospital
-
Stockholm, Sweden
- Sodersjukhuset
-
Trollhattan, Sweden
- Norra Alvsborgs lans Hospital
-
Varberg, Sweden
- Varberg Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients presenting within 6 h after onset of chest pain lasting for more than 30 min and with significant ST-segment elevation on ECG.
Exclusion Criteria:
- BP >180/110
- Known bleeding disorder
- Cardiogenic shock
- CPR>10 min
- Ongoing anticoagulant therapy
- Renal insufficiency
- Weight >120 kg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: thrombolysis
|
comparison to primary PCI
Other Names:
|
ACTIVE_COMPARATOR: invasive
|
comparison to thrombolysis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With ST-segment Elevation Resolution Equal or More Than 50%
Time Frame: 120 minutes after inclusion
|
ST-segment elevation resolution was measured in the lead with most prominent ST elevation at time of inclusion
|
120 minutes after inclusion
|
Number of Patients With Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3
Time Frame: 5-7 days after inclusion
|
Thrombolysis In Myocardial Infarction (TIMI) flow grade in the infarct related artery 5-7 days after inclusion.
|
5-7 days after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Stroke
Time Frame: 30 days
|
30 days
|
Death
Time Frame: 30 days
|
30 days
|
Reinfarction
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lars Grip, M.D. PhD, Sahlgren's University Hospital/S
- Study Chair: Leif Svensson, M.D. PhD, Stockholm South General Hospital
- Study Chair: Johan Herlitz, M.D. PhD, Sahlgren's University Hospital/S
- Study Chair: Mikael Dellborg, M.D. PhD, Sahlgren's University Hospital/O
- Study Chair: Ake Ohlsson, M.D. PhD, Stockholm South General Hospital
- Study Chair: Mikael Aasa, M.D., Stockholm South General Hospital
Publications and helpful links
General Publications
- Svensson L, Aasa M, Dellborg M, Gibson CM, Kirtane A, Herlitz J, Ohlsson A, Karlsson T, Grip L. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006 Apr;151(4):798.e1-7. doi: 10.1016/j.ahj.2005.09.013.
- Aasa M, Kirtane AJ, Dellborg M, Gibson MC, Prahl-Abrahamsson U, Svensson L, Grip L. Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention. Coron Artery Dis. 2007 Nov;18(7):513-8. doi: 10.1097/MCA.0b013e3282c1fdb6.
- Aasa M, Henriksson M, Dellborg M, Grip L, Herlitz J, Levin LA, Svensson L, Janzon M. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial. Am Heart J. 2010 Aug;160(2):322-8. doi: 10.1016/j.ahj.2010.05.008.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SWEDES 23/09/01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myocardial Infarction
-
Henry Ford Health SystemAbiomed Inc.Enrolling by invitationAcute Myocardial Infarction | Cardiogenic Shock | STEMI | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction | NSTEMI | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction of Right Ventricle (Disorder) | Acute Myocardial Infarction of Left VentricleUnited States
-
Jordan Collaborating Cardiology GroupCardiovascular Academy GroupTerminatedTriggers of Acute Myocardial Infarction | Time of Onset of Acute Myocardial Infarction | Long-term Prognosis After Acute Myocardial InfarctionJordan
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
Medical Center of South ArkansasWithdrawnAcute Coronary Syndrome | Acute ST Segment Elevation Myocardial InfarctionUnited States
-
Yuan's General HospitalKaohsiung Veterans General Hospital.; Sin-Lau HospitalUnknownAcute Myocardial Infarction, of Inferolateral Wall | Acute Myocardial Infarction, of Inferoposterior WallTaiwan
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Acute Coronary Syndrome | Acute Myocardial Infarction | Metabolic DisturbanceGreece
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Sheba Medical CenterCompletedNon ST Elevation Myocardial Infarction | Acute Coronary SyndromesIsrael
-
Medstar Health Research InstituteWithdrawnST-elevation Myocardial Infarction | Acute Myocardial InfarctionUnited States
-
Hennepin Healthcare Research InstituteSiemens HealthineersActive, not recruitingAcute Coronary Syndrome | Acute Myocardial InfarctionUnited States
Clinical Trials on reteplase 10+10 U
-
The University of Texas Health Science Center,...CompletedMyocardial Infarction | Heart Disease | Acute Myocardial InfarctionUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Ministry of Health and Population, EgyptCompletedPainful Diabetic NeuropathyEgypt
-
Celularity IncorporatedCompletedDiabetic Foot | Peripheral Arterial DiseaseUnited States
-
ClinAmygateAswan University HospitalRecruitingCholecystolithiasis | Cholecystitis; Gallstone | Cholecystitis, ChronicEgypt
-
Jas ChahalCompleted
-
BNM Clinic and ResearchCompletedDental Restoration, Permanent
-
Celularity IncorporatedTerminatedDiabetic Foot | Peripheral Arterial DiseaseUnited States
-
AerasEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Completed
-
Merry, Graham, M.D.CompletedNonexudative Age-related Macular DegenerationUnited States, Canada